ELI LILLY & Co

Pharmaceutical Preparations·INDIANAPOLIS, IN·FY end 12/31·CIK 59478

Named Executive Officers

FY 2025

Executive	Salary	Stock	Options	Bonus / Inc.	Other	Total
David A. RicksChair, President, and Chief Executive Officer	$1.7M	$23.3M	—	—	$10.9M	$736.2K
Anat HakimExecutive Vice President, General Counsel and Secretary	$1.0M	$6.0M	—	—	$2.7M	$162.6K
Daniel M. SkovronskyM.D., Ph.D.	$1.5M	$12.0M	—	—	$4.1M	$159.3K
Jake Van NaardenExecutive Vice President and President, Lilly Oncology and Head of Corporate Business Development	$920.2K	$4.5M	—	—	$2.1M	$72.5K
Lucas MontarceExecutive Vice President and Chief Financial Officer	$1.0M	$5.0M	—	—	$2.4M	$60.0K

David A. Ricks · FY 2025

Stock awards$23.3M65%

Salary$1.7M5%

Other$10.9M30%

TSR % vs. CEO comp actually paid · 5 fiscal years · Item 402(v) disclosure

TSR

CEO comp

FY21

+66%

$76M

FY22

+123%

$64M

FY23

+259%

$121M

FY24

+378%

$81M

FY25

+571%

$75M

Need at least two fiscal years of proxy data to draw the trend line. The ingestion worker will populate prior-year proxies as it processes them.